Waitlist and Transplant Outcomes in Organ Donation After Circulatory Death: Trends in the United States

Ann Surg. 2023 Oct 1;278(4):609-620. doi: 10.1097/SLA.0000000000005947. Epub 2023 Jun 19.

Abstract

Objectives: To summarize waitlist and transplant outcomes in kidney, liver, lung, and heart transplantation using organ donation after circulatory death (DCD).

Background: DCD has expanded the donor pool for solid organ transplantation, most recently for heart transplantation.

Methods: The United Network for Organ Sharing registry was used to identify adult transplant candidates and recipients in the most recent allocation policy eras for kidney, liver, lung, and heart transplantation. Transplant candidates and recipients were grouped by acceptance criteria for DCD versus brain-dead donors [donation after brain death (DBD)] only and DCD versus DBD transplant, respectively. Propensity matching and competing-risks regression was used to model waitlist outcomes. Survival was modeled using propensity matching and Kaplan-Meier and Cox regression analysis.

Results: DCD transplant volumes have increased significantly across all organs. Liver candidates listed for DCD organs were more likely to undergo transplantation compared with propensity-matched candidates listed for DBD only, and heart and liver transplant candidates listed for DCD were less likely to experience death or clinical deterioration requiring waitlist inactivation. Propensity-matched DCD recipients demonstrated an increased mortality risk up to 5 years after liver and kidney transplantation and up to 3 years after lung transplantation compared with DBD. There was no difference in 1-year mortality between DCD and DBD heart transplantation.

Conclusions: DCD continues to expand access to transplantation and improves waitlist outcomes for liver and heart transplant candidates. Despite an increased risk for mortality with DCD kidney, liver, and lung transplantation, survival with DCD transplant remains acceptable.

MeSH terms

  • Adult
  • Brain Death
  • Death
  • Graft Survival
  • Humans
  • Liver Transplantation*
  • Organ Transplantation*
  • Retrospective Studies
  • Tissue Donors
  • Tissue and Organ Procurement*
  • Treatment Outcome
  • United States